哌嗪-2,3-二酮 | 13092-86-9

• 物质功能分类: 生物 - 细胞培养 - 添加剂
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 哌嗪-2,3-二酮
• 中文别名: 2,3-双氧哌嗪
• 英文名称: diketopiperazine
• 英文别名: piperazine-2,3-dione；2,3-piperazinedione
• CAS: 13092-86-9
• 化学式: C₄H₆N₂O₂
• mdl: MFCD00053421
• 分子量: 114.104
• InChiKey: JTHRRMFZHSDGNJ-UHFFFAOYSA-N

物化性质

• 熔点：
  285 °C (decomp)
• 沸点：
  85-86 °C(Press: 76 Torr)
• 密度：
  1.246±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于DMSO（轻微超声处理）、甲醇（轻微超声处理）

计算性质

• 辛醇/水分配系数(LogP)：
  -1
• 重原子数：
  8
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  58.2
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 海关编码：
  2933599090

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : 2,3-Diketopiperazine
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Skin irritation (Category 2)
Eye irritation (Category 2)
Skin sensitization (Category 1)
Specific target organ toxicity - single exposure (Category 3)
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Irritating to eyes, respiratory system and skin. May cause sensitization by skin contact.
Label elements
Labelling according Regulation (EC) No 1272/2008 [CLP]
Pictogram
Signal word Warning
Hazard statement(s)
H315 Causes skin irritation.
H317 May cause an allergic skin reaction.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.
Precautionary statement(s)
P261 Avoid breathing dust.
P280 Wear protective gloves.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Supplemental Hazard none
Statements
According to European Directive 67/548/EEC as amended.
Hazard symbol(s)
R-phrase(s)
R36/37/38 Irritating to eyes, respiratory system and skin.
R43 May cause sensitization by skin contact.
S-phrase(s)
S26 In case of contact with eyes, rinse immediately with plenty of water and
seek medical advice.
S36/37 Wear suitable protective clothing and gloves.
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C4H8N2O3
Molecular Weight : 132,12 g/mol
Component Concentration
2,3-Diketopiperazine
-

---

Section 4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Indication of any immediate medical attention and special treatment needed
no data available

---

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure
adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end uses
no data available

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under
appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: -1,332
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

---

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
May cause allergic skin reaction.
The preceding data, or interpretation of data, was determined using Quantitative Structure Activity
Relationship (QSAR) modeling.
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
Inhalation - May cause respiratory irritation.
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. Causes respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. Causes skin irritation.
Eyes Causes serious eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Additional Information
RTECS: Not available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material. Dissolve or mix the material with a
combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

---

SECTION 15 - REGULATORY INFORMATION
N/A

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  哌嗪-2,3-二酮 在 sodium hydroxide 、 锌 作用下， 生成 哌嗪
  参考文献：
  名称：

  DE66461

  摘要：

  公开号：
• 作为产物：
  描述：

  草酰胺 、 乙二胺 在 1,4-二氧六环 、 盐酸 作用下， 生成 哌嗪-2,3-二酮
  参考文献：
  名称：

  Goulding; Pollard, Journal of the American Chemical Society, 1948, vol. 70, p. 1968

  摘要：

  DOI：
• 作为试剂：
  描述：

  N-Boc-L-正亮氨酸 、 N-苄基甘氨酸乙酯 、 N,N'-二环己基碳二亚胺 在 1-Benzyl-3(S)-n-butylpiperazine-2,5-dione 、 哌嗪-2,3-二酮 、 正己烷 作用下， 以to give the title compound as a white powder (12.0 g)的产率得到1-Benzyl-3(S)-n-butylpiperazine-2,5-dione
  参考文献：
  名称：

  Inhibitors of farnesyl-protein transferase

  摘要：

  本发明涉及抑制法尼酰蛋白转移酶（FTase）和致癌基因蛋白Ras的法尼酰化的化合物。本发明还涉及包含本发明化合物的化疗组合物以及抑制法尼酰蛋白转移酶和致癌基因蛋白Ras的方法。式A的化合物代表本发明的化合物：##STR1##

  公开号：

  US05736539A1

文献信息

• 2-oxo-1-[[(substituted sulfonyl)amino]carbonyl]azetidines
  申请人：E. R. Squibb & Sons, Inc.

  公开号：US04743685A1

  公开（公告）日：1988-05-10

  Antibacterial activity is exhibited by 2-azetidinones having a 3-acylamino substituent and having an activating group in the 1-position of the formula ##STR1##

  2-氮杂环丙酮具有3-酰氨基取代基并在分子式的1位具有活化基团，表现出抗菌活性。
• METHOD FOR PREPARING AN AMINO ACID FROM 2 AMINOBUTYROLACTONE
  申请人：Huet Robert

  公开号：US20130184474A1

  公开（公告）日：2013-07-18

  The invention relates to a method for preparing an amino acid, or its salts, from 2-aminobutyrolactone (2ABL), said amino acid fitting the formula I, XCH 2 CH 2 CHNH 2 COOH, wherein X is such that X − represents a nucleophilic ion, according to which N-carboxylation of 2-aminobutyrolactone (2ABL) is achieved with carbon dioxide, and the thereby obtained 2ABL carbamate is reactive with an XH reagent or its salts.

  该发明涉及一种从2-氨基丁酸内酯（2ABL）制备氨基酸或其盐的方法，所述氨基酸符合以下公式I，XCH2CH2CHNH2COOH，其中X是X−代表亲核离子的物质，根据该方法，通过二氧化碳实现2-氨基丁酸内酯（2ABL）的N-羧基化，并且由此获得的2ABL氨基甲酸酯与XH试剂或其盐具有反应性。
• 一种哌嗪类中间体及其制备方法与应用
  申请人：华南理工大学

  公开号：CN112608303A

  公开（公告）日：2021-04-06

  本申请属于化学药物技术领域,涉及一种哌嗪类中间体及其制备方法与应用，制备方法包括：通过将5‑氯‑2‑(1H‑四唑‑1‑基)苯四氟硼酸重氮盐的无水二甲基亚砜溶剂与哌嗪‑2,3‑二酮加入碱性溶液中，并在催化剂的作用下反应，生成1‑(5‑氯‑2‑(1H‑四唑‑1‑基)苯基)哌嗪‑2,3‑二酮，不仅可以避免采用剧毒的化合物，实现安全生产，而且生产工艺简单，产物收率高，纯度好，利于产业化应用。
• Cyclic peptide antitumor agents
  申请人：Silverman B. Richard

  公开号：US20050159346A1

  公开（公告）日：2005-07-21

  Cyclic peptide compounds and derivatives thereof having antitumor activity as shown by treatment of human melanoma, pancreatic, breast, prostate cancer cells.

  环肽化合物及其衍生物通过治疗人类黑色素瘤、胰腺癌、乳腺癌、前列腺癌细胞表现出抗肿瘤活性。
• Self-extinguishing polymeric compositions
  申请人：Montedison S.p.A.

  公开号：US04336182A1

  公开（公告）日：1982-06-22

  Thermoplastic polymers, such as polypropylene, are rendered anti-flaming and self-extinguishing by addition of ammonium or amine phosphate and a nitrogen-containing water-insoluble oligomer or polymer containing in the monomeric unit a --CO--group attached to a ##STR1## group, wherein n is 2 or 3, being part of a ring, e.g., poly(carbonylpiperazine).

  热塑性聚合物，例如聚丙烯，通过添加磷酸铵或胺磷酸和含有氮的水不溶性寡聚物或聚合物，其中单体单位中含有连接到##STR1##基团的--CO--基团，其中n为2或3，是环的一部分，例如聚（羰基哌嗪），使其防火且具有自灭火性。